2016 Q4 Form 10-K Financial Statement

#000087504518000005 Filed on February 01, 2018

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2016 Q2
Revenue $2.872B $2.956B $2.894B
YoY Change 1.15% 6.4% 11.68%
Cost Of Revenue $378.5M $416.9M $370.3M
YoY Change 14.07% 34.48% 29.43%
Gross Profit $2.494B $2.539B $2.524B
YoY Change -0.56% 2.88% 9.47%
Gross Profit Margin 86.82% 85.9% 87.21%
Selling, General & Admin $495.5M $462.7M $492.4M
YoY Change -15.01% -3.16% 0.1%
% of Gross Profit 19.87% 18.22% 19.51%
Research & Development $533.9M $529.0M $473.1M
YoY Change -1.44% 1.75% -3.59%
% of Gross Profit 21.41% 20.84% 18.74%
Depreciation & Amortization $177.4M $180.2M $175.4M
YoY Change 13.5% 18.87% 21.3%
% of Gross Profit 7.11% 7.1% 6.95%
Operating Expenses $1.117B $991.7M $965.5M
YoY Change -10.31% -0.6% -1.74%
Operating Profit $1.376B $1.425B $1.461B
YoY Change 9.08% 3.9% 18.44%
Interest Expense -$56.50M $66.00M $65.90M
YoY Change -25.85% 323.08% 1036.21%
% of Operating Profit -4.11% 4.63% 4.51%
Other Income/Expense, Net -$2.600M -$58.10M -$58.50M
YoY Change -58.06% 277.27% 436.7%
Pretax Income $838.2M $1.367B $1.402B
YoY Change -22.8% 0.8% 14.71%
Income Tax $190.3M $337.0M $353.6M
% Of Pretax Income 22.7% 24.65% 25.22%
Net Earnings $649.2M $1.033B $1.050B
YoY Change -21.93% 6.97% 13.21%
Net Earnings / Revenue 22.6% 34.94% 36.27%
Basic Earnings Per Share $3.00 $4.72 $4.79
Diluted Earnings Per Share $2.99 $4.71 $4.79
COMMON SHARES
Basic Shares Outstanding 216.6M shares 218.9M shares 219.1M shares
Diluted Shares Outstanding 217.0M shares 219.4M shares 219.4M shares

Balance Sheet

Concept 2016 Q4 2016 Q3 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.895B $4.316B $3.797B
YoY Change 42.75% -26.13% 60.28%
Cash & Equivalents $2.327B $2.085B $1.362B
Short-Term Investments $2.569B $2.231B $2.435B
Other Short-Term Assets $1.093B $993.1M $1.027B
YoY Change 30.64% 15.22% 36.98%
Inventory $1.002B $1.010B $996.4M
Prepaid Expenses
Receivables $1.442B $1.468B $1.293B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.732B $8.092B $7.448B
YoY Change 30.33% -12.72% 32.55%
LONG-TERM ASSETS
Property, Plant & Equipment $2.502B $2.387B $2.302B
YoY Change 14.36% 17.71% 25.26%
Goodwill $3.669B $3.420B $3.167B
YoY Change 37.75% 41.96% 47.01%
Intangibles $3.808B $3.870B $3.968B
YoY Change -6.78% -7.45% -7.62%
Long-Term Investments $4.159B $4.324B $4.592B
YoY Change 7.52% 52.58% 60.95%
Other Assets $1.336B $1.240B $1.153B
YoY Change 20.6% 38.93% 53.41%
Total Long-Term Assets $14.14B $14.01B $14.07B
YoY Change 10.47% 22.31% 26.27%
TOTAL ASSETS
Total Short-Term Assets $8.732B $8.092B $7.448B
Total Long-Term Assets $14.14B $14.01B $14.07B
Total Assets $22.88B $22.10B $21.51B
YoY Change 17.29% 6.64% 28.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $279.8M $274.0M $225.9M
YoY Change 4.64% 9.06% -20.09%
Accrued Expenses $1.506B $875.0M $903.0M
YoY Change 36.78% 5.17% 9.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.000M $5.000M $5.000M
YoY Change 0.0% 0.0% 66.67%
Total Short-Term Liabilities $3.420B $2.500B $2.516B
YoY Change 32.67% -5.1% -1.55%
LONG-TERM LIABILITIES
Long-Term Debt $6.513B $6.530B $6.538B
YoY Change -0.14% 0.02% 1035.07%
Other Long-Term Liabilities $722.5M $862.1M $951.0M
YoY Change -20.24% 0.08% 3.85%
Total Long-Term Liabilities $722.5M $862.1M $951.0M
YoY Change -20.24% 0.08% 3.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.420B $2.500B $2.516B
Total Long-Term Liabilities $722.5M $862.1M $951.0M
Total Liabilities $10.75B $9.990B $10.11B
YoY Change 6.1% -1.69% 141.54%
SHAREHOLDERS EQUITY
Retained Earnings $15.07B $15.03B $14.23B
YoY Change 23.45% 25.26% 28.96%
Common Stock $100.0K $100.0K $100.0K
YoY Change 0.0% -19.35% -22.48%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.612B $2.612B $2.612B
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 22.60M shares
Shareholders Equity $12.14B $12.12B $11.40B
YoY Change
Total Liabilities & Shareholders Equity $22.88B $22.10B $21.51B
YoY Change 17.29% 6.64% 28.38%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2016 Q2
OPERATING ACTIVITIES
Net Income $649.2M $1.033B $1.050B
YoY Change -21.93% 6.97% 13.21%
Depreciation, Depletion And Amortization $177.4M $180.2M $175.4M
YoY Change 13.5% 18.87% 21.3%
Cash From Operating Activities $1.582B $991.3M $998.2M
YoY Change 52.05% 10.71% -4.69%
INVESTING ACTIVITIES
Capital Expenditures -$183.3M -$280.7M -$108.2M
YoY Change -1.5% 22.47% -16.71%
Acquisitions
YoY Change
Other Investing Activities -$398.4M $316.9M -$627.9M
YoY Change -75.43% -141.65% -44.11%
Cash From Investing Activities -$581.7M $36.20M -$736.1M
YoY Change -67.82% -103.66% -41.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -726.5M -305.3M -15.80M
YoY Change -63.65% -110.5% 338.89%
NET CHANGE
Cash From Operating Activities 1.582B 991.3M 998.2M
Cash From Investing Activities -581.7M 36.20M -736.1M
Cash From Financing Activities -726.5M -305.3M -15.80M
Net Change In Cash 273.7M 722.2M 246.3M
YoY Change -109.9% -74.33% -217.51%
FREE CASH FLOW
Cash From Operating Activities $1.582B $991.3M $998.2M
Capital Expenditures -$183.3M -$280.7M -$108.2M
Free Cash Flow $1.765B $1.272B $1.106B
YoY Change 43.92% 13.11% -6.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 biib Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
327000000 USD
CY2016Q4 biib Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
276800000 USD
CY2017Q4 biib Available For Sale Securities Debt Maturities After Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsFairValue
327300000 USD
CY2016 biib Average Maturity Of Marketable Securities
AverageMaturityOfMarketableSecurities
P12M
CY2017 biib Average Maturity Of Marketable Securities
AverageMaturityOfMarketableSecurities
P17M
CY2015 biib Collaboration Profit Sharing
CollaborationProfitSharing
0 USD
CY2016 biib Collaboration Profit Sharing
CollaborationProfitSharing
10200000 USD
CY2017 biib Collaboration Profit Sharing
CollaborationProfitSharing
112300000 USD
CY2016Q4 biib Collaborationexpensesaccrual
Collaborationexpensesaccrual
130900000 USD
CY2017Q4 biib Collaborationexpensesaccrual
Collaborationexpensesaccrual
183700000 USD
CY2017 biib Compensation Expense Over Purchase Period
CompensationExpenseOverPurchasePeriod
The fair value of the look-back provision plus the 15% discount
CY2016Q4 biib Computer Software And Hardware
ComputerSoftwareAndHardware
746800000 USD
CY2017Q4 biib Accrued Expenses On Funding Commitment Related To Clinical Research
AccruedExpensesOnFundingCommitmentRelatedToClinicalResearch
40000000 USD
CY2015 biib Adjustments To Product Revenue Reserves Relating To Sales In Prior Years
AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears
32300000 USD
CY2016 biib Adjustments To Product Revenue Reserves Relating To Sales In Prior Years
AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears
16700000 USD
CY2017 biib Adjustments To Product Revenue Reserves Relating To Sales In Prior Years
AdjustmentsToProductRevenueReservesRelatingToSalesInPriorYears
-6000000 USD
CY2016Q4 biib Available For Sale Securities Debt Maturities After Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveYearsAmortizedCost
277500000 USD
CY2017Q4 biib Computer Software And Hardware
ComputerSoftwareAndHardware
767100000 USD
CY2015 biib Current Provisions To Product Revenue Reserves Relating To Sales In Current Year
CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear
2229400000 USD
CY2016 biib Current Provisions To Product Revenue Reserves Relating To Sales In Current Year
CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear
2668000000 USD
CY2017 biib Current Provisions To Product Revenue Reserves Relating To Sales In Current Year
CurrentProvisionsToProductRevenueReservesRelatingToSalesInCurrentYear
2917300000 USD
CY2017 biib Debt Instrument Make Whole Provision Redemption Price Percentage
DebtInstrumentMakeWholeProvisionRedemptionPricePercentage
1.01
CY2016Q4 biib Deferred Tax Liabilities Depreciation Amortization Other
DeferredTaxLiabilitiesDepreciationAmortizationOther
113500000 USD
CY2017Q4 biib Deferred Tax Liabilities Depreciation Amortization Other
DeferredTaxLiabilitiesDepreciationAmortizationOther
107900000 USD
CY2016 biib Discount Rate Recognized In Compensation Expense
DiscountRateRecognizedInCompensationExpense
0.15
CY2016Q4 biib Due From Unconsolidated Joint Business
DueFromUnconsolidatedJointBusiness
300600000 USD
CY2017Q4 biib Due From Unconsolidated Joint Business
DueFromUnconsolidatedJointBusiness
532600000 USD
CY2015 biib Effective Income Tax Rate Reconciliation Manufacturing Deduction
EffectiveIncomeTaxRateReconciliationManufacturingDeduction
-0.018
CY2016 biib Effective Income Tax Rate Reconciliation Manufacturing Deduction
EffectiveIncomeTaxRateReconciliationManufacturingDeduction
-0.019
CY2017 biib Effective Income Tax Rate Reconciliation Manufacturing Deduction
EffectiveIncomeTaxRateReconciliationManufacturingDeduction
-0.019
CY2017 biib Estimated Useful Lives Of Leasehold Improvements
EstimatedUsefulLivesOfLeaseholdImprovements
Lesser of the useful life or the term of the respective lease
CY2017 biib Interest In Subsidiary
InterestInSubsidiary
1.00
CY2016Q4 biib Inventorynetcurrentandnoncurrent
Inventorynetcurrentandnoncurrent
1039400000 USD
CY2017Q4 biib Inventorynetcurrentandnoncurrent
Inventorynetcurrentandnoncurrent
925500000 USD
CY2016Q4 biib Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities
InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities
47400000 USD
CY2017Q4 biib Investment In Biotechnology Companies That Are Determined To Be Unconsolidated Variable Interest Entities
InvestmentInBiotechnologyCompaniesThatAreDeterminedToBeUnconsolidatedVariableInterestEntities
48300000 USD
CY2013Q2 biib Loss Contingency Adjustment Related To Claim Amount Percent
LossContingencyAdjustmentRelatedToClaimAmountPercent
0.5
CY2017Q4 biib Net Minimum Lease Payments
NetMinimumLeasePayments
428500000 USD
CY2017Q4 biib Net Minimum Lease Payments Thereafter
NetMinimumLeasePaymentsThereafter
199800000 USD
CY2017Q4 biib Net Minimum Lease Payments With In Five Year
NetMinimumLeasePaymentsWithInFiveYear
43700000 USD
CY2017Q4 biib Net Minimum Lease Payments With In Four Year
NetMinimumLeasePaymentsWithInFourYear
44600000 USD
CY2017Q4 biib Net Minimum Lease Payments With In One Year
NetMinimumLeasePaymentsWithInOneYear
48300000 USD
CY2017Q4 biib Net Minimum Lease Payments With In Three Year
NetMinimumLeasePaymentsWithInThreeYear
44500000 USD
CY2017Q4 biib Net Minimum Lease Payments With In Two Year
NetMinimumLeasePaymentsWithInTwoYear
47600000 USD
CY2016 biib Noncontrollinginterestincreasedecreaseother
Noncontrollinginterestincreasedecreaseother
1500000 USD
CY2017 biib Noncontrollinginterestincreasedecreaseother
Noncontrollinginterestincreasedecreaseother
15800000 USD
CY2017 biib Number Of Share Based Compensation Plans Pursuant To Which Awards Are Currently Being Made
NumberOfShareBasedCompensationPlansPursuantToWhichAwardsAreCurrentlyBeingMade
3 Plan
CY2017 biib Payment Terms Of Accounts Receivable
PaymentTermsOfAccountsReceivable
30 to 90 days
CY2015 biib Payments Returns Applied Against Product Revenue Reserves Relating To Current Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear
1666600000 USD
CY2016 biib Payments Returns Applied Against Product Revenue Reserves Relating To Current Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear
2099500000 USD
CY2017 biib Payments Returns Applied Against Product Revenue Reserves Relating To Current Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToCurrentYear
2232800000 USD
CY2015 biib Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear
351600000 USD
CY2016 biib Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear
609000000 USD
CY2017 biib Payments Returns Applied Against Product Revenue Reserves Relating To Prior Year
PaymentsReturnsAppliedAgainstProductRevenueReservesRelatingToPriorYear
534400000 USD
CY2016 biib Percentage Of Market Value Per Share Of Common Stock
PercentageOfMarketValuePerShareOfCommonStock
0.85
CY2017Q4 biib Potential Future Milestone Payments Commitment To Third Party Approximately
PotentialFutureMilestonePaymentsCommitmentToThirdPartyApproximately
4200000000 USD
CY2017 biib Purchase Price Of Common Stock Under Espp
PurchasePriceOfCommonStockUnderEspp
85% of the lower of (i) the fair market value per share of the common stock on the first business day of an offering period and (ii) the fair market value per share of the common stock on the purchase date
CY2015 biib Revenues In Percentage From Anti Cd20 Therapeutic Programs
RevenuesInPercentageFromAntiCD20TherapeuticPrograms
0.12
CY2016 biib Revenues In Percentage From Anti Cd20 Therapeutic Programs
RevenuesInPercentageFromAntiCD20TherapeuticPrograms
0.11
CY2017 biib Revenues In Percentage From Anti Cd20 Therapeutic Programs
RevenuesInPercentageFromAntiCD20TherapeuticPrograms
0.13
CY2015 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
1339200000 USD
CY2016Q1 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
329500000 USD
CY2016Q2 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
349200000 USD
CY2016Q3 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
317600000 USD
CY2016Q4 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
318200000 USD
CY2016 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
1314500000 USD
CY2017Q1 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
340600000 USD
CY2017Q2 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
397100000 USD
CY2017Q3 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
406500000 USD
CY2017Q4 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
415000000 USD
CY2017 biib Revenuesfromanti Cd20therapeuticprograms
RevenuesfromantiCD20therapeuticprograms
1559200000 USD
CY2015 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
196300000 USD
CY2016 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
189800000 USD
CY2017 biib Share Based Compensation Expense Included In Costs And Expenses
ShareBasedCompensationExpenseIncludedInCostsAndExpenses
160100000 USD
CY2016Q4 biib Totaldeferredchargesandprepaidtaxes
Totaldeferredchargesandprepaidtaxes
989800000 USD
CY2017Q4 biib Totaldeferredchargesandprepaidtaxes
Totaldeferredchargesandprepaidtaxes
617700000 USD
CY2017 biib Weighted Average Period To Recognize Cost Of Nonvested Awards
WeightedAveragePeriodToRecognizeCostOfNonvestedAwards
P1Y11M
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
211562686 shares
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0000875045
CY2017Q2 dei Entity Public Float
EntityPublicFloat
57220188450 USD
CY2017 dei Entity Registrant Name
EntityRegistrantName
BIOGEN INC.
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
279800000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
395500000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1441600000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1787000000 USD
CY2016Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
195800000 USD
CY2017Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
206700000 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1439300000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1559100000 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-59500000 USD
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-224000000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-319900000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-318400000 USD
CY2016Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 USD
CY2017Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
97800000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
69000000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
600000 USD
CY2015 us-gaap Advertising Expense
AdvertisingExpense
108600000 USD
CY2016 us-gaap Advertising Expense
AdvertisingExpense
106300000 USD
CY2017 us-gaap Advertising Expense
AdvertisingExpense
75200000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
183200000 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
169400000 USD
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
138100000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
207300000 USD
CY2016 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
204400000 USD
CY2017 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
169700000 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
382600000 USD
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
385600000 USD
CY2017 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
814700000 USD
CY2016Q4 us-gaap Assets
Assets
22876800000 USD
CY2017Q4 us-gaap Assets
Assets
23652600000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
8732200000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
7873300000 USD
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5406300000 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
5173000000 USD
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
5398000000 USD
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
5172500000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2900000 USD
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2300000 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
11200000 USD
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2800000 USD
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
5406300000 USD
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
5173000000 USD
CY2016Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2568600000 USD
CY2017Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
2115200000 USD
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
2559700000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
2730000000 USD
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2552600000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
2730000000 USD
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2569100000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
2116000000 USD
CY2016Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2568600000 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
2115200000 USD
CY2015 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
1500000 USD
CY2016 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
3300000 USD
CY2017 us-gaap Available For Sale Securities Gross Realized Gains
AvailableForSaleSecuritiesGrossRealizedGains
3000000 USD
CY2015 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
3500000 USD
CY2016 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
4300000 USD
CY2017 us-gaap Available For Sale Securities Gross Realized Losses
AvailableForSaleSecuritiesGrossRealizedLosses
22400000 USD
CY2016Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
2829400000 USD
CY2017Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
3057300000 USD
CY2016Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1107800000 USD
CY2017Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1213600000 USD
CY2017Q4 us-gaap Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
1100000000 USD
CY2016Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
580800000 USD
CY2017Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
844600000 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1204900000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1308000000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2326500000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1573800000 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
148900000 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1049800000 USD
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-792100000 USD
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2039600000 USD
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1229400000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0005
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
238500000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
235300000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
215900000 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
211500000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
100000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3382500000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3606900000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2540600000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-46200000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
7100000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-131000000 USD
CY2015 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3428700000 USD
CY2016 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3599800000 USD
CY2017 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2671600000 USD
CY2016Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
658600000 USD
CY2017Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1276000000 USD
CY2016Q4 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
134000000 USD
CY2017Q4 us-gaap Construction Payable Current And Noncurrent
ConstructionPayableCurrentAndNoncurrent
159700000 USD
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1240400000 USD
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1478700000 USD
CY2017 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1630000000 USD
CY2015 us-gaap Costs And Expenses
CostsAndExpenses
5872800000 USD
CY2016 us-gaap Costs And Expenses
CostsAndExpenses
6298400000 USD
CY2017 us-gaap Costs And Expenses
CostsAndExpenses
6929700000 USD
CY2015 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1214100000 USD
CY2016 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1304300000 USD
CY2017 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
2201400000 USD
CY2015 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
54500000 USD
CY2016 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
52900000 USD
CY2017 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
108600000 USD
CY2015 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1307200000 USD
CY2016 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1412300000 USD
CY2017 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2367000000 USD
CY2015 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
38600000 USD
CY2016 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
55100000 USD
CY2017 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
57000000 USD
CY2016Q4 us-gaap Debt Current
DebtCurrent
4700000 USD
CY2017Q4 us-gaap Debt Current
DebtCurrent
3200000 USD
CY2016Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
6808400000 USD
CY2017Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
6483300000 USD
CY2017 us-gaap Debt Instrument Maturity Date Description
DebtInstrumentMaturityDateDescription
less than 90 days
CY2017 us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1
CY2015 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-129600000 USD
CY2016 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-125600000 USD
CY2017 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
241000000 USD
CY2015 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-14100000 USD
CY2016 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-45600000 USD
CY2017 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-159200000 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-145600000 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-175000000 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
91700000 USD
CY2015 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1900000 USD
CY2016 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-3800000 USD
CY2017 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
9900000 USD
CY2016Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
459800000 USD
CY2017Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
378800000 USD
CY2016Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
250600000 USD
CY2017Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
147800000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
1071800000 USD
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
831800000 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
65900000 USD
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
209800000 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
49000000 USD
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
25100000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
201100000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
60000000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
61500000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
26900000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
48800000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16100000 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
16600000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
490100000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
358600000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
376600000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
250700000 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
93100000 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
122600000 USD
CY2015 us-gaap Depreciation
Depreciation
217900000 USD
CY2016 us-gaap Depreciation
Depreciation
309300000 USD
CY2017 us-gaap Depreciation
Depreciation
266300000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600400000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
682700000 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1081000000 USD
CY2017Q4 us-gaap Derivative Remaining Maturity1
DerivativeRemainingMaturity1
P12M
CY2017 us-gaap Derivative Remaining Maturity1
DerivativeRemainingMaturity1
P21M
CY2016Q4 us-gaap Disposal Group Including Discontinued Operation Goodwill1
DisposalGroupIncludingDiscontinuedOperationGoodwill1
0 USD
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
15.38
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.44
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.79
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.72
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.00
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
16.96
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.47
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.07
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.80
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.41
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
11.94
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
15.34
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.43
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.79
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.71
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.99
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
16.93
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.46
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.07
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.79
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.40
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
11.92
CY2015 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-45800000 USD
CY2016 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-31300000 USD
CY2017 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
39400000 USD
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.251
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.479
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.229
CY2015 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.100
CY2016 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.096
CY2017 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.111
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.010
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.012
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Depreciation And Amortization
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization
0.014
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
0.009
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.007
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.005
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.007
CY2015 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.003
CY2016 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.004
CY2017 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.005
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.009
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.008
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.013
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.014
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.008
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
282900000 USD
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
297700000 USD
CY2015 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
11000000 USD
CY2016 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
14600000 USD
CY2017 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
9600000 USD
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
168000000 USD
CY2015 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
55800000 USD
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
54000000 USD
CY2017 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
42800000 USD
CY2015 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
11900000 USD
CY2016 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
4000000 USD
CY2017 us-gaap Employee Service Share Based Compensation Tax Benefit From Exercise Of Stock Options
EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions
3400000 USD
CY2017Q4 us-gaap Extinguishment Of Debt Gain Loss Net Of Tax
ExtinguishmentOfDebtGainLossNetOfTax
5200000 USD
CY2015 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-30500000 USD
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-14800000 USD
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-62700000 USD
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
53200000 USD
CY2017 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
6700000 USD
CY2016 us-gaap Fair Value Measurements Changes In Valuation Techniques
FairValueMeasurementsChangesInValuationTechniques
0
CY2017 us-gaap Fair Value Measurements Changes In Valuation Techniques
FairValueMeasurementsChangesInValuationTechniques
0
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3934000000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4385000000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
423500000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
242300000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
254300000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
381600000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
401800000 USD
CY2015 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-32700000 USD
CY2016 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9800000 USD
CY2017 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
6300000 USD
CY2016Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
60600000 USD
CY2017Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
55300000 USD
CY2017Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions
FutureMinimumSubleaseRentalsSaleLeasebackTransactions
188500000 USD
CY2017Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Thereafter
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter
71300000 USD
CY2017Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Five Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFiveYears
22000000 USD
CY2017Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Four Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears
22300000 USD
CY2017Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within One Year
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear
24300000 USD
CY2017Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Three Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears
23900000 USD
CY2017Q4 us-gaap Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years
FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears
24700000 USD
CY2015 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
23800000 USD
CY2016 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
29200000 USD
CY2017 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1303900000 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
199300000 USD
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
622300000 USD
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-227400000 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
174400000 USD
CY2017 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
4500000 USD
CY2015 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-3800000 USD
CY2016 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
6000000 USD
CY2017 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-36300000 USD
CY2015Q4 us-gaap Goodwill
Goodwill
2663800000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
3669300000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
4632500000 USD
CY2016 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1026900000 USD
CY2017 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1267300000 USD
CY2017Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
0 USD
CY2016 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
-21400000 USD
CY2017 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
10000000 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
2413800000 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
2523900000 USD
CY2016Q3 us-gaap Gross Profit
GrossProfit
2538900000 USD
CY2016Q4 us-gaap Gross Profit
GrossProfit
2493500000 USD
CY2016 us-gaap Gross Profit
GrossProfit
9970100000 USD
CY2017Q1 us-gaap Gross Profit
GrossProfit
2426100000 USD
CY2017Q2 us-gaap Gross Profit
GrossProfit
2712200000 USD
CY2017Q3 us-gaap Gross Profit
GrossProfit
2707800000 USD
CY2017Q4 us-gaap Gross Profit
GrossProfit
2797800000 USD
CY2017 us-gaap Gross Profit
GrossProfit
10643900000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3386700000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3655400000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3540400000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1380600000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1277600000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1588400000 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4767300000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4933000000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5128800000 USD
CY2015 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12500000 USD
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1161600000 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1237300000 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2458700000 USD
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1674800000 USD
CY2016 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1642200000 USD
CY2017 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1066400000 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-29000000 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
241400000 USD
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
435600000 USD
CY2015 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-429400000 USD
CY2016 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-232600000 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
165600000 USD
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
94500000 USD
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
127000000 USD
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-59100000 USD
CY2017 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
76600000 USD
CY2015 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
31100000 USD
CY2016 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-13900000 USD
CY2017 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
232000000 USD
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
83200000 USD
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
69500000 USD
CY2017 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2400000 USD
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
7742300000 USD
CY2017Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
8264600000 USD
CY2016Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3808300000 USD
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3879600000 USD
CY2015 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
10400000 USD
CY2016 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
12900000 USD
CY2017 us-gaap Interest Costs Capitalized
InterestCostsCapitalized
30700000 USD
CY2015 us-gaap Interest Expense
InterestExpense
95500000 USD
CY2016 us-gaap Interest Expense
InterestExpense
260000000 USD
CY2017 us-gaap Interest Expense
InterestExpense
250800000 USD
CY2015 us-gaap Interest Paid Net
InterestPaidNet
39100000 USD
CY2016 us-gaap Interest Paid Net
InterestPaidNet
281200000 USD
CY2017 us-gaap Interest Paid Net
InterestPaidNet
281700000 USD
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
170300000 USD
CY2017Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
157400000 USD
CY2016Q4 us-gaap Inventory Net
InventoryNet
1001600000 USD
CY2017Q4 us-gaap Inventory Net
InventoryNet
902700000 USD
CY2016Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
37800000 USD
CY2017Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
22800000 USD
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
170400000 USD
CY2017Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
162400000 USD
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
698700000 USD
CY2017Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
605700000 USD
CY2015 us-gaap Inventory Write Down
InventoryWriteDown
41900000 USD
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
48200000 USD
CY2017 us-gaap Inventory Write Down
InventoryWriteDown
76900000 USD
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
22100000 USD
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
63400000 USD
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
78500000 USD
CY2016Q4 us-gaap Land
Land
137800000 USD
CY2017Q4 us-gaap Land
Land
141200000 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
68600000 USD
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
68700000 USD
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
65300000 USD
CY2016Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
123700000 USD
CY2017Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
80600000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
10748200000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
11054500000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22876800000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23652600000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3419900000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3368200000 USD
CY2017Q4 us-gaap Liability For Uncertain Tax Positions Current
LiabilityForUncertainTaxPositionsCurrent
77300000 USD
CY2015 us-gaap Line Of Credit Facility Expiration Period
LineOfCreditFacilityExpirationPeriod
P5Y
CY2017Q4 us-gaap Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
0 USD
CY2015Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
1000000000 USD
CY2016Q4 us-gaap Litigation Reserve
LitigationReserve
454800000 USD
CY2017Q4 us-gaap Litigation Reserve
LitigationReserve
0 USD
CY2017Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
1250000000 USD
CY2015 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 USD
CY2016Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
454800000 USD
CY2016 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
454800000 USD
CY2017 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
6512700000 USD
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
5935000000 USD
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
16400000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
0 USD
CY2016Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1700000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
0 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
3500000000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
3200000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
1000000000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1500000000 USD
CY2017Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0 USD
CY2017Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
6003200000 USD
CY2016Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1105800000 USD
CY2017Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1207700000 USD
CY2016Q4 us-gaap Minority Interest
MinorityInterest
-11500000 USD
CY2017Q4 us-gaap Minority Interest
MinorityInterest
-14700000 USD
CY2015 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
60000000 USD
CY2017 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
150000000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
783100000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1052600000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2380000000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4553600000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2484800000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2963100000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3919400000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4587200000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4551000000 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
3547000000 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
970900000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
1049800000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
1032900000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-95800000 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
649200000 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
3702800000 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
747600000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
862800000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
1226100000 USD
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-297400000 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
2539100000 USD
CY2015 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
46200000 USD
CY2016 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-7100000 USD
CY2017 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
131000000 USD
CY2016 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
7500000 USD
CY2015 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
10900000 USD
CY2016 us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
600000 USD
CY2015Q4 us-gaap Noncurrent Assets
NoncurrentAssets
2187600000 USD
CY2016Q4 us-gaap Noncurrent Assets
NoncurrentAssets
2501800000 USD
CY2017Q4 us-gaap Noncurrent Assets
NoncurrentAssets
3182400000 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-123700000 USD
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-217400000 USD
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-215400000 USD
CY2017 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
4891000000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
5150400000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
5344200000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
617000000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
72600000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
65700000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
66900000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
68400000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
72300000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
271100000 USD
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
685700000 USD
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
636900000 USD
CY2016Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1093300000 USD
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
962000000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1335800000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1027500000 USD
CY2017Q4 us-gaap Other Commitment
OtherCommitment
460000000 USD
CY2015 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-400000 USD
CY2016 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-10000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
9200000 USD
CY2015 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
6500000 USD
CY2016 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-92500000 USD
CY2017 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
-42700000 USD
CY2015 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-61500000 USD
CY2016 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
47600000 USD
CY2017 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-162300000 USD
CY2015 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-96400000 USD
CY2016 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-138600000 USD
CY2017 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
158700000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
164500000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1500000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-164500000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-95900000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1500000 USD
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1365400000 USD
CY2015 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
0 USD
CY2016 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
0 USD
CY2015 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
6200000 USD
CY2016 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-5100000 USD
CY2017 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
4100000 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-1300000 USD
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-600000 USD
CY2017 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-12700000 USD
CY2015 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
172300000 USD
CY2016 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
4000000 USD
CY2017 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-31500000 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
110800000 USD
CY2016 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
51600000 USD
CY2017 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-193800000 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1700000 USD
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-10600000 USD
CY2017 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3500000 USD
CY2016Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2903500000 USD
CY2017Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2901300000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
722500000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1628700000 USD
CY2015 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-129900000 USD
CY2016 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-89000000 USD
CY2017 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-162100000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13800000 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-17000000 USD
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13100000 USD
CY2015 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
236100000 USD
CY2016Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
87900000 USD
CY2016Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
79000000 USD
CY2016Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
98600000 USD
CY2016Q4 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
50900000 USD
CY2016 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
316400000 USD
CY2017Q1 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
90000000 USD
CY2017Q2 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
41600000 USD
CY2017Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
48800000 USD
CY2017Q4 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
179600000 USD
CY2017 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
360000000 USD
CY2015 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
44500000 USD
CY2016 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
22800000 USD
CY2017 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
11000000 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5000000000 USD
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1000000000 USD
CY2017 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
302700000 USD
CY2017Q4 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
7700000 USD
CY2015 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
47500000 USD
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
70900000 USD
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8500000 USD
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5300000 USD
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
6864900000 USD
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
7913200000 USD
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
5355200000 USD
CY2015 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
198800000 USD
CY2016 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2017 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2015 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
0 USD
CY2016 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
0 USD
CY2017 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
120000000 USD
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15400000 USD
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
111600000 USD
CY2017 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
975400000 USD
CY2015 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
850000000 USD
CY2016 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1200000000 USD
CY2017 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
1200000000 USD
CY2015 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
13100000 USD
CY2016 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
38600000 USD
CY2017 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
3000000 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
643000000 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
616100000 USD
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
867400000 USD
CY2015 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
56100000 USD
CY2016 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
CY2017 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
134100000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
8000000 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Prepaid Taxes
PrepaidTaxes
817000000 USD
CY2017Q4 us-gaap Prepaid Taxes
PrepaidTaxes
657600000 USD
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5930500000 USD
CY2016 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2017 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 USD
CY2015 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5200000 USD
CY2016 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2800000 USD
CY2017 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-8600000 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
4063000000 USD
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
7378900000 USD
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
5565900000 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6300000 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2200000 USD
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
700000 USD
CY2015 us-gaap Profit Loss
ProfitLoss
3593200000 USD
CY2016Q1 us-gaap Profit Loss
ProfitLoss
969200000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
1048400000 USD
CY2016Q3 us-gaap Profit Loss
ProfitLoss
1030200000 USD
CY2016Q4 us-gaap Profit Loss
ProfitLoss
647900000 USD
CY2016 us-gaap Profit Loss
ProfitLoss
3695700000 USD
CY2017Q1 us-gaap Profit Loss
ProfitLoss
747500000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
862800000 USD
CY2017Q3 us-gaap Profit Loss
ProfitLoss
1226100000 USD
CY2017Q4 us-gaap Profit Loss
ProfitLoss
-166300000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
2670100000 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3941100000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4741500000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2501800000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3182400000 USD
CY2015 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-171000000 USD
CY2016 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3400000 USD
CY2017 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
44200000 USD
CY2015 us-gaap Repayments Of Debt
RepaymentsOfDebt
2100000 USD
CY2016 us-gaap Repayments Of Debt
RepaymentsOfDebt
2700000 USD
CY2017 us-gaap Repayments Of Debt
RepaymentsOfDebt
560900000 USD
CY2015 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2012800000 USD
CY2016 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1973300000 USD
CY2017 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2253600000 USD
CY2015 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2016 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
0 USD
CY2017 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
120000000 USD
CY2015 us-gaap Restructuring Charges
RestructuringCharges
93400000 USD
CY2016 us-gaap Restructuring Charges
RestructuringCharges
33100000 USD
CY2017 us-gaap Restructuring Charges
RestructuringCharges
900000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15071600000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
15810400000 USD
CY2015 us-gaap Revenues
Revenues
10763800000 USD
CY2016Q1 us-gaap Revenues
Revenues
2726800000 USD
CY2016Q2 us-gaap Revenues
Revenues
2894200000 USD
CY2016Q3 us-gaap Revenues
Revenues
2955800000 USD
CY2016Q4 us-gaap Revenues
Revenues
2872000000 USD
CY2016 us-gaap Revenues
Revenues
11448800000 USD
CY2017Q1 us-gaap Revenues
Revenues
2810700000 USD
CY2017Q2 us-gaap Revenues
Revenues
3078400000 USD
CY2017Q3 us-gaap Revenues
Revenues
3077800000 USD
CY2017Q4 us-gaap Revenues
Revenues
3307000000 USD
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2466000000 USD
CY2016Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2539600000 USD
CY2016Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2502900000 USD
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9817900000 USD
CY2017 us-gaap Revenues
Revenues
12273900000 USD
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
9188500000 USD
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2309400000 USD
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
42000 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
54.06
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
53.83
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Other Share Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherShareIncreaseDecrease
0 shares
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
50.89
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
55.11
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.00
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice
0.00
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y4M
CY2017 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
6200000 shares
CY2017Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2380100000 USD
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
14000 shares
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
125100000 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
52100000 USD
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
45800000 USD
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2639700000 USD
CY2017Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2622500000 USD
CY2017Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2712400000 USD
CY2017 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
10354700000 USD
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2113100000 USD
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1947900000 USD
CY2017 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1935500000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
161400000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
154800000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
128000000 USD
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
38000000 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10400000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3400000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
10000 shares
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0 shares
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11100000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
66000 shares
CY2015 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
54200000 USD
CY2016 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
43700000 USD
CY2017 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
40500000 USD
CY2015Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000000 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
10809000000 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
9372800000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
12140100000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
12612800000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
10814000000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9374900000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12128600000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
12598100000 USD
CY2017 us-gaap Stockholders Equity Note Spinoff Transaction
StockholdersEquityNoteSpinoffTransaction
-852800000 USD
CY2017 us-gaap Stockholders Equity Other
StockholdersEquityOther
17500000 USD
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
231900000 USD
CY2017Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
68200000 USD
CY2015 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2016 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2017 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
22600000 shares
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
23800000 shares
CY2015 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
16800000 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2611700000 USD
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2977100000 USD
CY2015 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5000000000 USD
CY2016 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1000000000 USD
CY2015 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
1800000 USD
CY2016 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
-49800000 USD
CY2017 us-gaap Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax
UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax
113000000 USD
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
131500000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
67900000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
32400000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
66800000 USD
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
49900000 USD
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
13300000 USD
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
21800000 USD
CY2015 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
42500000 USD
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
64300000 USD
CY2017 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
44600000 USD
CY2015 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
3100000 USD
CY2016 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
9100000 USD
CY2017 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
4800000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
10500000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
7200000 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
5700000 USD
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
19500000 USD
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
36300000 USD
CY2017 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
7300000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
25200000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
16100000 USD
CY2015 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1200000 USD
CY2016 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1400000 USD
CY2017 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1400000 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
15700000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
26900000 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
64300000 USD
CY2014Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
483800000 USD
CY2015Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
662700000 USD
CY2016Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
605500000 USD
CY2017Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
761600000 USD
CY2015 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
500000 shares
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
400000 shares
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
231200000 shares
CY2016Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219300000 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219400000 shares
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
219400000 shares
CY2016Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
217000000 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
218800000 shares
CY2017Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215900000 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212200000 shares
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
211800000 shares
CY2017Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212000000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
213000000 shares
CY2015 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
4600000 shares
CY2016 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
700000 shares
CY2017 us-gaap Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation
WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation
3700000 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
230700000 shares
CY2016Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218900000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
219100000 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218900000 shares
CY2016Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
216600000 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
218400000 shares
CY2017Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215600000 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211900000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211400000 shares
CY2017Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
211500000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212600000 shares
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Financial instruments that potentially subject us to concentrations of credit risk include cash and cash equivalents, investments, derivatives and accounts receivable. We attempt to minimize the risks related to cash and cash equivalents and investments by investing in a broad and diverse range of financial instruments as previously defined by us. We have established guidelines related to credit ratings and maturities intended to safeguard principal balances and maintain liquidity. Our investment portfolio is maintained in accordance with our investment policy, which defines allowable investments, specifies credit quality standards and limits the credit exposure of any single issuer. We minimize credit risk resulting from derivative instruments by choosing only highly rated financial institutions as counterparties.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">Concentrations of credit risk with respect to receivables, which are typically unsecured, are somewhat mitigated due to the wide variety of customers and markets using our products, as well as their dispersion across many different geographic areas. The majority of our accounts receivable arise from product sales in the U.S. and Europe and have standard payment terms that generally require payment within </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">30 to 90 days</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">. We monitor the financial performance and creditworthiness of our customers so that we can properly assess and respond to changes in their credit profile. We continue to monitor these conditions and assess their possible impact on our business. </font></div><div style="line-height:120%;padding-top:12px;text-align:left;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">As of </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">December&#160;31, 2017</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">2016</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, two wholesale distributors individually accounted for approximately </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">26.5%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">19.0%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">37.2%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;"> and </font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">19.2%</font><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">, of accounts receivable, net, respectively. </font></div></div>
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:Franklin Gothic Book,sans-serif;font-size:10pt;">The preparation of our consolidated financial statements requires us to make estimates, judgments and assumptions that may affect the reported amounts of assets, liabilities, equity, revenues and expenses and related disclosure of contingent assets and liabilities. On an on-going basis we evaluate our estimates, judgments and methodologies. We base our estimates on historical experience and on various other assumptions that we believe are reasonable, the results of which form the basis for making judgments about the carrying values of assets, liabilities and equity and the amount of revenues and expenses. Actual results may differ from these estimates under different assumptions or conditions.</font></div></div>

Files In Submission

Name View Source Status
0000875045-18-000005-index-headers.html Edgar Link pending
0000875045-18-000005-index.html Edgar Link pending
0000875045-18-000005.txt Edgar Link pending
0000875045-18-000005-xbrl.zip Edgar Link pending
acquiredinprocessrdchart.jpg Edgar Link pending
amortofacqintanassetschart.jpg Edgar Link pending
anticd20revenueschart.jpg Edgar Link pending
avonex.jpg Edgar Link pending
benepalia02.jpg Edgar Link pending
biib-20171231.xml Edgar Link completed
biib-20171231.xsd Edgar Link pending
biib-20171231x10k.htm Edgar Link pending
biib-20171231xex1010.htm Edgar Link pending
biib-20171231xex1011.htm Edgar Link pending
biib-20171231xex1028.htm Edgar Link pending
biib-20171231xex1031.htm Edgar Link pending
biib-20171231xex1032.htm Edgar Link pending
biib-20171231xex1033.htm Edgar Link pending
biib-20171231xex21.htm Edgar Link pending
biib-20171231xex23.htm Edgar Link pending
biib-20171231xex311.htm Edgar Link pending
biib-20171231xex312.htm Edgar Link pending
biib-20171231xex321.htm Edgar Link pending
biib-20171231_cal.xml Edgar Link unprocessable
biib-20171231_def.xml Edgar Link unprocessable
biib-20171231_lab.xml Edgar Link unprocessable
biib-20171231_pre.xml Edgar Link unprocessable
biogenidec.jpg Edgar Link pending
biogenlogostandarda06.jpg Edgar Link pending
biosimilarschart.jpg Edgar Link pending
collabprofitsharechart.jpg Edgar Link pending
corporatestrategy.jpg Edgar Link pending
costofsaleschart.jpg Edgar Link pending
equityinlossofinvesteechart.jpg Edgar Link pending
fampyra.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
financialhighlightschart.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
flixabi.jpg Edgar Link pending
fumaderm.jpg Edgar Link pending
gazyva.jpg Edgar Link pending
geographicsaleschart.jpg Edgar Link pending
glonfvcontconsideration.jpg Edgar Link pending
incometaxprovisionchart.jpg Edgar Link pending
interferonchart.jpg Edgar Link pending
noncontrollinginterestchart.jpg Edgar Link pending
ocrevusmultiplesclerosislogo.jpg Edgar Link pending
oiechart.jpg Edgar Link pending
otherrevenueschart.jpg Edgar Link pending
part1researchanddevchart.jpg Edgar Link pending
plegridy.jpg Edgar Link pending
principalproductschart.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R123.htm Edgar Link pending
R124.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
rdpiechart2015.jpg Edgar Link pending
rdpiechart2016.jpg Edgar Link pending
rdpiechart2017.jpg Edgar Link pending
report.css Edgar Link pending
researchanddevelopmentchart.jpg Edgar Link pending
reserveschart.jpg Edgar Link pending
restructuringchargeschart.jpg Edgar Link pending
rituxan.jpg Edgar Link pending
sellinggeneraladminchart.jpg Edgar Link pending
Show.js Edgar Link pending
spinrazachart.jpg Edgar Link pending
spinrazalogonewa01.jpg Edgar Link pending
stockperformancechart.jpg Edgar Link pending
tecfidera.jpg Edgar Link pending
tecfiderachart.jpg Edgar Link pending
teclitigationchart.jpg Edgar Link pending
tysabri.jpg Edgar Link pending
tysabrichart.jpg Edgar Link pending
zinbryta.jpg Edgar Link pending
zinbrytachart.jpg Edgar Link pending